×

Health Care Equipment and Supplies Health Care Equipment

  • Sept 28- The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc's "artificial pancreas" designed to automatically deliver the right dose of insulin to patients with type 1 diabetes. Jeffrey Shuren, director of the FDA's medical device division said in a statement. "This device will mean peace of mind, in knowing a person will be in normal blood...

  • Sept 8- Medical device maker Abbott Laboratories and Alere Inc agreed on Thursday to work with a mediator to settle their dispute over Abbott's role in obtaining U.S. antitrust clearance for its $5.8 billion takeover of the diagnostics company, but Alere voiced concern about the speed of the process. The companies are considering using former Delaware...

  • Sept 6- Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business. Danaher will pay $53 per share in cash, a premium of 54 percent to Cepheid's close of $34.42 on Friday. 1/ 8 nPn10sKcxa. Cepheid had revenue of $539 million last year, and is expecting $618...

  • Aug 31- Tecomet Inc, a privately held U.S. contract manufacturer of medical devices and surgical instruments, is exploring a sale that could value it at more than $1 billion, including debt, according to people familiar with the matter. Genstar Capital, the private equity firm that owns Tecomet, has hired investment bank William Blair& Company, LLC to run an auction...

  • St. Jude reopens

    St. Jude reopens, with fractionally higher stocks, CNBC's Bob Pisani reports.

  • Check out the companies making headlines after the bell Tuesday.

  • Doctor patient with heart montior

    HeartWare stock soared more than 90 percent on news that the company will be acquired by Medtronic.

  • Fit classrooms

    CNBC's Diana Olick takes a look at bringing deskercise to the classroom.

  • An employee uses a Thermo Fisher Scientific Inc. X Series 2 inductively coupled plasma mass spectrometry machine to analyze copper concentrate samples inside the Central Geological Laboratory in Ulaanbaatar, Mongolia.

    Thermo Fisher Scientific said it would buy FEI for about $4.2 billion to gain access to its signature electron microscopy technology.

  • Prophix is an innovative video toothbrush paired with an iOS app.

    An invention that debuted Thursday could let you see all the spots you're missing when you brush.

  • People with Samsung Gear VR

    A team at Oxford University have used virtual reality devices to help treat patients with paranoia, showing how VR could help health care.

  • Founder & CEO of Theranos Elizabeth Holmes.

    NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.

  • Game changer in heart health: EW CEO

    Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.

  • An employee uses a microscope at the Medtronic assembly plant in Tijuana, Mexico.

    Bill Ackman should have listened!

  • Sworkit, a personal trainer in your pocket

    Ben Young, Sworkit founder & CEO, explains how a new fitness app allows users to customize personalized workout videos.

  • Investing in immunotherapy

    Loncar Investments CEO, Brad Loncar says immunotherapy is the most innovative, high-growth area in the biotech space, while describing the company’s ETF.

  • This picture shows a logo mark of Toshiba.

    Toshiba has granted Canon exclusive negotiating rights for its medical equipment unit after a hotly contested auction.

  • The future of health care technology

    Jonathan Adiri, CEO of Healthy.io, discusses how smart phones, wearables and tech will impact health care.

  • Regulators discover serious deficiencies at Theranos lab

    U.S. health inspectors found problems at Theranos' northern California laboratory.

  • In an interview with CNBC, the NIH director said people may be "a little cynical" because of cancer's casualty rate, but researchers 'had its number.'